Travellers’ adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas

Background: According to current guidelines, atovaquone/proguanil (AP) malaria chemoprophylaxis is taken once daily during travel, and continued for seven days after return from malaria-endemic areas. However, pharmacokinetic data and studies on drug-sparing AP regimens suggest that AP could possibl...

Full description

Saved in:
Bibliographic Details
Main Authors: Jenny Lea Schnyder, David Cornelis Birkhoff, Myrthe Celine Jarings, Sabine Margot Hermans, Martin Peter Grobusch, Hanna Katrien de Jong
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Travel Medicine and Infectious Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1477893925000183
Tags: Add Tag
No Tags, Be the first to tag this record!